March Board of Governors Meeting
The meeting began with a summary presentation on the 2022 Congress on Healthcare Leadership. As the meeting has now taken place, we were pleased that nearly 4,000 executives and other healthcare professionals from across the country and world attended the four-day conference in Chicago. Of note, attendance was high among CEOs and other C-suite executives, as 25% of attendees were in those roles. In addition, there were 153 education sessions, with more than 300 speakers. The Board also was informed of the Virtual Leadership Symposium’s success, held in April. Over 1,400 attended this two-day online event.
Business Report
ACHE remains financially solid with strong revenues and diligent expense management. The Board reviewed and accepted the report of the Finance Committee on the 2021 financial results. As part of the Board’s review of the 2021 performance, it was reported that ACHE achieved its corporate performance objectives:
- Member/Fellow Growth: Target Achieved. The total number of Members and Fellows as of Dec. 31, 2021, is 38,276, and the total membership is 48,311. This reflects an increase from 37,193 paid Members, and a total of 47,308 from this same time last year.
- Member/Fellow Attrition: Threshold Achieved. Attrition was 7,527 Members and Fellows through December 2021, compared to 7,480 through December 2020.
- Fellows Exams Passed: Maximum Achieved. Through Dec. 31, 2021, a total of 918 Members have attempted the Board of Governors Exam, with 607 of those passing, resulting in a 66% pass rate. Compared to 2020 at this same point in time, 355 Members attempted the Exam, with 256 passing, resulting in a 72% pass rate.
- Earned Credits From National ACHE Face-to-Face and Virtual Face-to-Face Education: Maximum Achieved. F2F credits earned from paid registrants totaled 100,157, mostly through the success of Congress.
- Member Satisfaction: Threshold Achieved. We conducted the Member Needs Survey, the primary survey sent to Members, Fellows and leaders annually. This year’s satisfaction score achieved our threshold with a weighted average of 4.12.
- Consolidated Corporate Financials: Target Achieved. The excess (deficit) of revenues over expenses from operations of $1,350,687 for the year ending Dec. 31, 2021, exceeds the original target of $(1,894,586) for a favorable variance of $3,245,274.
President’s Report
The Board reviewed an overview of ACHE’s Strategic Plan investment priorities for 2022–2024. These priorities include DEI’s next level strategy, FACHE and chapters. The Board remains committed to investing in ACHE’s advancement of technology to serve its members.
Strategic Plan Update
The Board was given a detailed update of the 2022–2024 Strategic Plan.
Strategic Imperative: Catalyst
In our role as Catalyst, ACHE will commit to leading for equity and safety.
The Board discussed ACHE’s DEI Next Level Strategy to be a thought leader and champion to drive solutions that advance equity. Currently, research is underway to inform the Board’s decision in June on next steps.
Strategic Imperative: Connector
In our role as Connector, ACHE will commit to growing our professional community across the healthcare continuum by leveraging our partnerships with chapters and other organizations.
It was reported to the Board that ACHE is examining new ways to enhance the ACHE-chapter partnership. The goal is to better leverage the role of chapter leaders and volunteers in providing value to members.
Strategic Imperative: Trusted Partner
In our role as Trusted Partner, ACHE will commit to deepening engagement with members and the healthcare community.
The Board discussed ACHE’s FACHE Leadership Campaign that will accelerate the adoption of board certification in healthcare management as an ACHE Fellow (FACHE®) as the gold standard for leading. The Board was also given a technology assessment update, in which ACHE will accelerate the use of technology to proactively meet the challenges of a rapidly changing environment and create unparalleled digital experiences for leaders.
In Other Business
The Board approved the 2022–2023 committee assignments. ACHE and the Foundation are fortunate to have nearly 700 volunteers serving on 40 committees to represent the voice and perspective of our diverse membership base.
The Board welcomed the newly elected Chair Officers and Governors who were elected by the Council of Regents. They officially took office March 26.
- Delvecchio S. Finley, FACHE, Chair-Elect
- Noel J. Cárdenas, FACHE
- Michael K. Givens, FACHE
- Michele R. Martz, CPA, FACHE
- Dodie McElmurray, FACHE
The Board of Governors also thanked the outgoing Immediate Past Chair and Governors for their dedicated service to ACHE and its Foundation.
June Board of Governors Meeting
The American College of Healthcare Executives and the Foundation of the American College of Healthcare Executives Board of Governors meetings were expected to take place June 26–28. The following is an overview of what was expected to take place:
Financials
The Board will receive financial statements for the current period, and ACHE’s and the Foundation of ACHE’s 2021 financial audit and report to the Audit Committee. The auditors will issue an unmodified opinion regarding the financial positions of ACHE and the Foundation of ACHE.
The Board will also receive and discuss the 2022 forecast and as well as an overview of planned board-level investments and initiatives. Overall, ACHE is financially well-positioned.
2022–2024 Strategy Session
The Board will discuss the overall goals for the Strategic Plan for 2022–2024. Chief among the priorities is the continued focus on ACHE’s diversity, equity and inclusion efforts, strengthening the Fellow credential, evolving ACHE support for chapters and advancement of technology to serve ACHE members.
President’s Report
The Board will be given an update on the strength of the FACHE® and the organization’s education and membership initiatives.
Next Meeting Planned
The next face-to-face meeting of the Board of Governors is scheduled for Dec. 5–6. Highlights of that meeting will be published in a future issue of Healthcare Executive.